LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

Search

West Pharmaceutical Services Inc

Cerrado

SectorSanidad

266.53 -1.99

Resumen

Variación precio

24h

Actual

Mínimo

265.11

Máximo

270.9

Métricas clave

By Trading Economics

Ingresos

8.2M

140M

Ventas

38M

804M

P/B

Media del Sector

39.864

77.671

BPA

1.96

Rentabilidad por dividendo

0.3

Margen de beneficios

17.406

Empleados

10,600

EBITDA

19M

217M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+28.26% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.30%

2.35%

Fecha Próximo Dividendo

4 feb 2026

Próxima Fecha de Ex Dividendo

28 ene 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-409M

19B

Apertura anterior

268.52

Cierre anterior

266.53

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

169 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

West Pharmaceutical Services Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

16 dic 2025, 23:46 UTC

Charlas de Mercado

Gold Edges Higher, Aided by Fed Rate-Cut Prospects -- Market Talk

16 dic 2025, 23:38 UTC

Charlas de Mercado

Nikkei May Rise on Possible Bargain-Hunting Interest -- Market Talk

16 dic 2025, 22:35 UTC

Adquisiciones, fusiones, absorciones

Santos: Sale Delivered Cash, Reduced Future Decommissioning Exposure

16 dic 2025, 22:35 UTC

Adquisiciones, fusiones, absorciones

Santos Sold 43% Stake in Petrel Fields, 100% of Tern Fields to Eni Australia

16 dic 2025, 22:33 UTC

Adquisiciones, fusiones, absorciones

Santos: A$40M Upfront Consideration, Up to A$20M in Contingent Payments

16 dic 2025, 22:33 UTC

Adquisiciones, fusiones, absorciones

Santos Sold 43% Operated Interest in Mahalo JV to Comet Ridge

16 dic 2025, 22:32 UTC

Adquisiciones, fusiones, absorciones

Santos Divests Two Noncore Assets as Part of Portfolio Optimization

16 dic 2025, 22:25 UTC

Adquisiciones, fusiones, absorciones

Westgold's Indicative Timetable Points to Early February Completion

16 dic 2025, 22:24 UTC

Adquisiciones, fusiones, absorciones

Westgold: Divestment Aligns With Broader Corporate Strategy

16 dic 2025, 22:23 UTC

Adquisiciones, fusiones, absorciones

Westgold: Deferred Payment Based on Performance Hurdles

16 dic 2025, 22:23 UTC

Adquisiciones, fusiones, absorciones

Westgold Will Receive A$15M Cash, A$19.6M in Alicanto Shares

16 dic 2025, 22:23 UTC

Adquisiciones, fusiones, absorciones

Westgold to Receive A$30M Deferred Payment in Cash or Shares

16 dic 2025, 22:22 UTC

Adquisiciones, fusiones, absorciones

Westgold Divesting Noncore Operating Asset for A$64.6M

16 dic 2025, 22:22 UTC

Adquisiciones, fusiones, absorciones

Westgold Agrees to Sell Mt Henry-Selene Project to Alicanto Minerals

16 dic 2025, 21:53 UTC

Ganancias

Lennar Misses Earnings Estimates. The Stock Is Dropping. -- Barrons.com

16 dic 2025, 21:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

16 dic 2025, 21:33 UTC

Adquisiciones, fusiones, absorciones

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- 2nd Update

16 dic 2025, 21:18 UTC

Adquisiciones, fusiones, absorciones

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- Update

16 dic 2025, 21:17 UTC

Adquisiciones, fusiones, absorciones

Worthington Enterprises to Buy LSI Group for About $205M >WOR

16 dic 2025, 21:16 UTC

Ganancias

Worthington Enterprises 2Q Sales $327.5M >WOR

16 dic 2025, 21:16 UTC

Ganancias

Worthington Enterprises 2Q Adj EPS 65c >WOR

16 dic 2025, 21:16 UTC

Ganancias

Worthington Enterprises 2Q EPS 55c >WOR

16 dic 2025, 21:15 UTC

Adquisiciones, fusiones, absorciones

Worthington Enterprises Agrees To Acquire Leading Metal Roof Components Manufacturer LSI Group >WOR

16 dic 2025, 21:05 UTC

Adquisiciones, fusiones, absorciones

Ecolab Closes Acquisition Of Ovivo's Electronics Ultrapure Water Business >ECL

16 dic 2025, 20:54 UTC

Adquisiciones, fusiones, absorciones

Warner to Reject Paramount Offer As Soon As Wednesday, Sources Say -- WSJ

16 dic 2025, 20:54 UTC

Adquisiciones, fusiones, absorciones

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- WSJ

16 dic 2025, 20:54 UTC

Adquisiciones, fusiones, absorciones

Warner to Recommend Existing Netflix Deal, Sources Say -- WSJ

16 dic 2025, 20:44 UTC

Charlas de Mercado

Russia-Ukraine Peace Efforts Send Crude to Near 5-Year Low -- Market Talk

16 dic 2025, 20:04 UTC

Charlas de Mercado

U.S. Natural Gas Extends Weather-Driven Losing Streak -- Market Talk

16 dic 2025, 20:01 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

Comparación entre iguales

Cambio de precio

West Pharmaceutical Services Inc previsión

Precio Objetivo

By TipRanks

28.26% repunte

Estimación a 12 Meses

Media 348.7 USD  28.26%

Máximo 375 USD

Mínimo 285 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para West Pharmaceutical Services Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

12 ratings

10

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

213.26 / 219.27Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

169 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat